Mitsubishi Tanabe Forms Plan To Improve Compliance Procedures
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma says it has drawn up plans to establish new compliance procedures to prevent a repeat of a subsidiary's manipulation of test data